PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Molecular Hepatology10.3350/cmh.2013.19.4.4172013194417Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndromeHae Rim Kim, Young Sun Lee, Hyung Joon Yim, Hyun Joo Lee, Ja Young Ryu, Hyun Jung Lee, Eileen L. Yoon, Sun Jae Lee, Jong Jin Hyun, Sung Woo Jung, Ja Seol Koo, Rok Sun Choung, Sang Woo Lee, Jai Hyun Choihttp://synapse.koreamed.org/pdf/10.3350/cmh.2013.19.4.417, http://synapse.koreamed.org/DOIx.php?id=10.3350/cmh.2013.19.4.417, http://www.e-cmh.org/upload/pdf/cmh-19-417.pdf
The Korean Journal of Medicine10.3904/kjm.2016.90.5.4062016905406-409Ischemic Colitis Caused by Terlipressin during Treatment of Hepatorenal SyndromeSe Jin Park, Seung Hyun Lee, Ju Yeol Heo, Ki Wook Kim, Kyung-Ah Kim, June Sung Leehttp://ekjm.org/upload/kjm-90-5-406.pdf, http://ekjm.org/journal/view.php?doi=10.3904/kjm.2016.90.5.406, http://www.ekjm.org/upload/kjm-90-5-406.pdf
Journal of Gastroenterology and Hepatology10.1111/j.1440-1746.2010.06583.x201126109-114Terlipressin in hepatorenal syndrome: Evidence for present indicationsHarshal Rajekar, Yogesh Chawlahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1440-1746.2010.06583.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.2010.06583.x/fullpdf
Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment10.1159/0003189992011178-188Safety of Terlipressin for Hepatorenal SyndromeAleksander Krag, Søren Møllerhttps://www.karger.com/Article/Pdf/318999
Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment10.1159/0003190002011189-197Terlipressin for Hepatorenal Syndrome: Novel Strategies and Future PerspectivesP. Angelihttps://www.karger.com/Article/Pdf/319000
Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment10.1159/0003189982011172-177Terlipressin for Hepatorenal Syndrome: Predictors of ResponseAndrés Cárdenas, Pere Ginèshttps://www.karger.com/Article/Pdf/318998
Critical Care10.1186/ccf-2000-6039200021Hepatorenal syndrome treatment with terlipressin and albuminMark Hamiltonhttp://link.springer.com/content/pdf/10.1186/ccf-2000-6039.pdf, http://link.springer.com/article/10.1186/ccf-2000-6039/fulltext.html, http://link.springer.com/content/pdf/10.1186/ccf-2000-6039.pdf
Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment10.1159/0003194382011163-171Terlipressin for Hepatorenal Syndrome: The US ExperienceApollo K. Musana, Arun J. Sanyalhttps://www.karger.com/Article/Pdf/319438
BMJ10.1136/bmj-2021-0679272022e067927Terlipressin induced ischaemic skin necrosis in a patient with hepatorenal syndromeHsing-Jou Su, Kuan-Yu Chen, Chun-Bing Chenhttp://data.bmj.org/tdm/10.1136/bmj-2021-067927, https://syndication.highwire.org/content/doi/10.1136/bmj-2021-067927
Journal of Hepatology10.1016/j.jhep.2014.09.0302015622493-495Transient increase in urine protein excretion during treatment with terlipressin and albumin for type-1 hepatorenal syndromeChiara Elia, Elsa Solà Vergés, Ezequiel Rodríguez, Pere Ginèshttps://api.elsevier.com/content/article/PII:S0168827814007247?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0168827814007247?httpAccept=text/plain